Results 51 to 60 of about 3,232,787 (374)

Throat infections and use of streptococcal antigen test and antibiotic treatment in general practice; a web-based survey

open access: yesScandinavian Journal of Primary Health Care, 2022
Objective The aim of this study was to investigate the use of streptococcal antigen tests and antibiotic prescription in general practice in Norway in relation to the national guidelines for sore throat.Design This study was based on a web-based survey ...
Hanne Puntervoll   +3 more
doaj   +1 more source

Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes

open access: yesTherapeutic Advances in Infectious Disease, 2022
Background: Despite the severity and frequency of streptococcal bloodstream infections (BSIs), the effectiveness of oral definitive therapy remains unknown.
Amy Kang, Richard Beuttler, Emi Minejima
doaj   +1 more source

Clinical presentation of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections in research and community settings.

open access: yesJournal of child and adolescent psychopharmacology, 2015
BACKGROUND The first cases of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) were described >15 years ago.
S. Swedo   +6 more
semanticscholar   +1 more source

Endolysins against Streptococci as an antibiotic alternative

open access: yesFrontiers in Microbiology, 2022
Multi-drug resistance has called for a race to uncover alternatives to existing antibiotics. Phage therapy is one of the explored alternatives, including the use of endolysins, which are phage-encoded peptidoglycan hydrolases responsible for bacterial ...
Kuan Yee Wong   +6 more
doaj   +1 more source

Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections

open access: yesScientific Reports, 2016
Drug-loaded nanoparticles (NPs) can improve infection treatment by ensuring drug concentration at the right place within the therapeutic window. Poly(lactic-co-glycolic acid) (PLGA) NPs are able to enhance drug localization in target site and to ...
Roberto Díez-Martínez   +6 more
semanticscholar   +1 more source

Streptococcal Infection: Issues of Pathogenesis, Role in the Formation of Somatic Pathology in Children

open access: yesAktualʹnaâ Infektologiâ, 2014
Streptococcal infections are the most common diseases of bacterial origin. Major importance in human pathology belongs to streptococci serogroup A. There are primary, secondary and rare forms of streptococcal infection.
Ye.V. Prokhorov, L.L. Chelpan
doaj   +1 more source

Pilus distribution among lineages of group b streptococcus: an evolutionary and clinical perspective [PDF]

open access: yes, 2014
<b>Background</b><p></p> Group B Streptococcus (GBS) is an opportunistic pathogen in both humans and bovines. Epidemiological and phylogenetic analyses have found strains belonging to certain phylogenetic lineages to be more ...
Davies, H Dele   +7 more
core   +1 more source

SG-APSIC1155: Drug susceptibility patterns of fulminant group G Streptococcus (GGS) infection as a re-emerging infectious disease in Japan

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2023
Objectives: Severe streptococcal infections are invasive, re-emerging infections that rapidly worsen and lead to death. Not only group A Streptococcus (GAS) but also group g Streptococcus (GGS) are the causative agents of this infection.
Masaaki Minami   +2 more
doaj   +1 more source

Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

open access: yesJournal of child and adolescent psychopharmacology, 2015
This is a case series describing 12 youths treated with intravenous immunoglobulin (IVIG) for pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS).
M. Kovacević, Paul J Grant, S. Swedo
semanticscholar   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

open access: yesMolecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy